Jump to content

Welcome to Sclero Forums!! How may we help you?


Adverse events during the Scleroderma Lung Study.

  • Please log in to reply
No replies to this topic

#1 Joelf


    Star Ruby Member

  • ISN Root Admin
  • PipPipPipPipPipPipPipPipPipPipPipPipPip
  • 4,829 posts
  • Location:West Sussex

Posted 20 July 2011 - 10:57 AM

Adverse events during the Scleroderma Lung Study.

Over 2 years, cyclophosphamide was associated with more AEs than placebo, including overall AEs and relative leukopenia. There were no differences in other AEs, including serious AEs, cancers, or deaths. (PubMed) Furst DE. Am J Med. 2011 May;124(5):459-67. (Also see: Clinical Trials)

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
Jo Frowde
ISN Assistant Webmaster
SD World Webmaster
ISN Sclero Forums Manager
ISN News Manager
ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)